Skip to main content
Log in

Leptin — Neue Erkenntnisse zur Pathogenese der Adipositas

Leptin — Novel concepts of the pathophysiology of obesity

  • Übersicht
  • Published:
Medizinische Klinik Aims and scope Submit manuscript

Zusammenfassung

□ Die Entdeckung des ob-Gens und seines Genproduktes Leptin führte zur Identifizierung eines schon seit Jahrzehnten postulierten «Sättigungsfaktors», der im Rahmen der Körpergewichtsregulation das Gehim über die peripheren Fettspeicher informiert und die weitere Nahrungsaufnahme reguliert. Schon bald wurde ein leptinbindender Rezeptor sowohl im Zentralnervensystem als auch in zahlreichen peripheren Organen identifiziert. Ein geschlossener Regelkreis zwischen peripheren Fettspeichern und zentralnervösem Leptinrezeptor scheint die Grundlage einer intakten Körpergewichtsregulation zu sein. Während die Adipositas des Menschen mit einer Resistenz gegenüber körpereigenem Leptin assoziiert ist, deren Ursachen noch weitgehend unbekannt sind, beruht die Adipositas verschiedener Tiermodelle auf der Unterbrechung dieses Regelkreises an unterschiedlichen Stellen. Auch bei der Manifestation von Insulinresistenz und Diabetes mellitus Typ II scheint Leptin eine mögliche Rolle zu spielen.

□ Nach Jahren der Stagnation in der Grundlagenforschung zur Adipositas konnten seit der Entdeckung von Leptin zahlreiche neue Erkenntnisse über die an der Adipositas beteiligten molekularen Mechanismen und Signaltransduktionswege gewonnen werden. Hieraus dürften sich neue, kausal orientierte Strategien zur Therapie der Adipositas ergeben.

Abstract

□ Cloning of the ob-gene and characterization of its gene product leptin has led to the identification of a satiety factor, which signals the amount of peripheral fat stores to the central nervous system and regulates further feeding behaviour, thus playing a central role in the regulation of body weight. Soon after cloning of the ob-gene, a leptin-binding receptor has been identified in the central nervous system as well as in various peripheral organs. A feedback loop between peripheral fat stores and leptin receptors in the central nervous system appears to play an important role in normal body weight regulation. In contrast to human obesity, which associated with leptin resistance of uncertain etiology, the obesity syndromes associated with several animal models are now known to result from the interruption of the feedback loop at different points. Moreover, leptin may play a role in manifestation of insulin resistance and type II diabetes.

□ Since the identification of leptin, a vast number of studies have been conducted to assess the molecular mechanisms and signal transduction pathways that are involved in the development and manifestation of obesity. From the large body of data generated to date, novel concepts of the regulation of energy balance and target strategies to control human obesity should soon be forthcoming.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250–2.

    Article  PubMed  CAS  Google Scholar 

  2. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996;17:305–11.

    Article  PubMed  CAS  Google Scholar 

  3. Barash IA, Cheung CC, Weigle DS, et al. Leptin is a metabolic signal to the reproductive system. Endocrinology 1996;137:3144–7.

    Article  PubMed  CAS  Google Scholar 

  4. Baumann H, Morella KK, White DW, et al. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci USA 1996;93:8374–8.

    Article  PubMed  CAS  Google Scholar 

  5. Becker DJ, Ongemba LN, Brichard V, Henquin J-C, Brichard SM. Diet- and diabetes-induced changes of ob gene expression in rat adipose tissue. FEBS Lett 1995;71:324–8.

    Article  Google Scholar 

  6. Bennett BD, Solar GP, Yuan JQ, Mathias J, Thomas GR, Matthews W. A role for leptin and its cognate receptor in hematopoiesis. Curr Biol 1996;6:1170–80.

    Article  PubMed  CAS  Google Scholar 

  7. Billington CJ, Briggs JE, Grace M, Levine AS. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am J Physiol 1991;260:R321–7.

    PubMed  CAS  Google Scholar 

  8. Boden G, Chen X, Mozzoli M, Ryan I. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 1996;81:3419–23.

    Article  PubMed  CAS  Google Scholar 

  9. Brabant G, Horn R, Mayr B, von zur Mühlen A, Honegger J, Buchfelder M. Serum leptin levels following hypothalamic surgery. Horm Metab Res 1996;28:728–31.

    Article  PubMed  CAS  Google Scholar 

  10. Bray MS, Boerwinkle E, Hanis CL. Ob gene not linked to human obesity in mexican American affected sib pairs from Starr County, Texas. Hum Genet 1996;98:590–5.

    Article  PubMed  CAS  Google Scholar 

  11. Burton BT, Foster WR, Hirsch J, van Itallie TB. Report of conference proceedings. Health implications of obesity: an NIH consensus development conference. Int J Obes 1985;9:155–70.

    PubMed  CAS  Google Scholar 

  12. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse of protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546–8.

    Article  PubMed  CAS  Google Scholar 

  13. Caprio S, Tamborlane WV, Silver D, et al. Hyperleptinemia: an early sign of juvenile obesity. Relations to body fat depots and insulin concentrations. Am J Physiol 1996;271:626–30.

    Google Scholar 

  14. Caro JF, Kolaczynski JW, Nyce MR, et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996;348:159–61.

    Article  PubMed  CAS  Google Scholar 

  15. Chehab FF, Lim ME, Ronghua L. Correction of the sterility defect in homozygous obese female mice by treatment with the recombinant human ob protein. Nature Genet 1996;12:318–20.

    Article  PubMed  CAS  Google Scholar 

  16. Chehab FF, Mounzih K, Lu R, Kim ME. Early onset of reproductive function in normal female mice treated with leptin. Science 1997;275:88–90.

    Article  PubMed  CAS  Google Scholar 

  17. Chen H, Charlat O, Tartaglia LA, et al. Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996;84:491–5.

    Article  PubMed  CAS  Google Scholar 

  18. Cheung C, Lok S. Kuijper J, et al. Distribution of leptin receptor (ob-R) mRNA in the central nervous system of the rat. 26th Annual Meeting of Society for Neuroscience, Washington, D.C., 1996. abstract.

  19. Cheung CC, Thornton JE, Kuijper JL, Weigle DS, Clifton DK, Steiner RA. Leptin is a metabolic gate for the onset of puberty in the female rat. Endocrinology 1997;138:855–8.

    Article  PubMed  CAS  Google Scholar 

  20. Chua SS, Chung WK, Wu-Peng XS, et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the ob (leptin) receptor. Science 1996;271:994–6.

    Article  PubMed  CAS  Google Scholar 

  21. Chua SS, White DW, Wu-Peng XS, et al. Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Lepr). Diabetes 1996;45:1141–3.

    Article  PubMed  CAS  Google Scholar 

  22. Cioffi JA, Shafer AW, Zupancic TJ, et al. Novel B219/OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction. Nature Med 1996;2:585–9.

    Article  PubMed  CAS  Google Scholar 

  23. Clement K, Garner C, Hager J, et al. Indication for linkage of the human ob gene region with extreme obesity. Diabetes 1996;45:687–90.

    Article  PubMed  CAS  Google Scholar 

  24. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996;274:1185–8.

    Article  PubMed  CAS  Google Scholar 

  25. Coleman DL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologica 1978;14:141–8.

    Article  CAS  Google Scholar 

  26. Considine RV, Considine EL, Williams CJ, Hyde TM, Caro JF. The hypothalamic leptin receptor in humans. Identification of incidental sequence polymorphism and absence of the db/db mouse and fa/fa rat mutations. Diabetes 1996;19:992–4.

    Article  Google Scholar 

  27. Considine RV, Considine EL, Williams CJ, et al. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest 1995;95:2986–8.

    Article  PubMed  CAS  Google Scholar 

  28. Considine RV, Considine EL, Williams CJ, et al. Mutation screening and identification of a sequnce variation in the human ob gene coding region. Biochem Biophys Res Commun 1996;220:735–9.

    Article  PubMed  CAS  Google Scholar 

  29. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentration in normal-weight and obese humans. N Engl J Med 1996;334:292–5.

    Article  PubMed  CAS  Google Scholar 

  30. Cusin I, Rohner-Jeanrenaud F, Stricker-Krongrad A, Jeanrenaud B. The weight-reducing effect of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats. Diabetes 1996;45:1446–50.

    Article  PubMed  CAS  Google Scholar 

  31. Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B. The ob gene and insulin. A relationship leading to clues to the understanding of obesity. Diabetes 1995;44:1467–70.

    Article  PubMed  CAS  Google Scholar 

  32. Dagago-Jack S, Fanelli C, Paramore D, Brothers J, Landt M. Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 1996;45:695–8.

    Article  Google Scholar 

  33. De Vos P, Saladin R, Auwerx J, Staels B. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 1995;270:15958–61.

    Article  PubMed  Google Scholar 

  34. Emilsson V, Liu YL, Cawthorne MA, Morton NM, Davenport M. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 1997;46:313–6.

    Article  PubMed  CAS  Google Scholar 

  35. Erickson JC, Hollopeter G, Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 1996;274:1704–7.

    Article  PubMed  CAS  Google Scholar 

  36. Frederich RC, Hamann A, Anderson S, Löllmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nature Med 1995;1:1311–4.

    Article  PubMed  CAS  Google Scholar 

  37. Friedman JM, Leibel RL. Tackling a weighty problem. Cell 1992;69:217–20.

    Article  PubMed  CAS  Google Scholar 

  38. Funahashi T, Shimomura I, Hiraoka H, et al. Enhanced expression of rat obese (ob) gene in adipose tissues of ventromedial hypothalamus (VMH)-lesioned rats. Biochem Biophys Res Commun 1995;211:469–75.

    Article  PubMed  CAS  Google Scholar 

  39. Geldschusz R, Horn R, Pötter E, von zur Mühlen A, Brabant G. Leptin plasma levels in healthy normal weight and obese human subjects: Exp Clin Endocrinol 1996;104: Suppl 1:148.

    Google Scholar 

  40. Golden PL, Maccagnan TJ, Pardridge WM. Human blood brain barrier leptin receptor. J Clin Invest 1997;99:14–8.

    Article  PubMed  CAS  Google Scholar 

  41. Grinspoon S, Gulick T, Askari H, et al. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab 1996;81:3861–3.

    Article  PubMed  CAS  Google Scholar 

  42. Grunfeld C, Zhao C, Fuller J, et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 1996;97:2152–7.

    Article  PubMed  CAS  Google Scholar 

  43. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543–56.

    Article  PubMed  CAS  Google Scholar 

  44. Hamilton BS, Paglia D, Kwan AYM, Deitel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nature Med 1995;1:953–6.

    Article  PubMed  CAS  Google Scholar 

  45. Horn R, Geldszus R, Pötter E, von zur Mühlen A, Brabant G. Radioimmunoassay for the detection of leptin in human serum. Exp Clin Endocrinol 1996;104: 454–8.

    Article  CAS  Google Scholar 

  46. Houseknecht KL, Mantzoros CS, Kuliawat R, Hadro E, Flier JS, Kahn BB. Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes 1996;45:1638–43.

    Article  PubMed  CAS  Google Scholar 

  47. Igel M, Kainulainen H, Brauners A, Becker W, Herberg L, Joost HG. Long-term and rapid regulation of ob mRNA levels in adipose tissue from normal (Sprague Dawley rats) and obese (db/db mice, fa/fa rats) rodents. Diabetologica 1996;39:758–65.

    Article  CAS  Google Scholar 

  48. Iida M, Murakami T, Ishida K, Mizuno A, Kuwajima M, Shima K. Substitution at codon 269 (glutamine-proline) of the leptin receptor (ob-R) cDNA is the only mutation found in the Zucker Fatty (fa/fa) rat. Biochem Biophys Res Commun 1996;224:597–604.

    Article  PubMed  CAS  Google Scholar 

  49. Isse N, Ogawa Y, Tamura N, et al. Structural organization and chromosomal assignment of the human obese gene. J. Biol. Chem. 270 (1995), 27728–27733.

    Article  PubMed  CAS  Google Scholar 

  50. Kennedy G. The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc Lond 1953;B140:578–92.

    Article  CAS  Google Scholar 

  51. Kieffer TJ, Heller RS, Habener JF. Leptin receptors expressed on pancreatic β-cells. Biochem Biophys Res Commun 1996;224:522–7.

    Article  PubMed  CAS  Google Scholar 

  52. Klein S, Coppack SW, Mohamed-Ali V, Landt M. Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 1996;45:984–7.

    Article  PubMed  CAS  Google Scholar 

  53. Kolaczynski JW, Considine RV, Ohannesian J, et al. Responses of leptin to short-term fasting and refeeding in humans. A link with ketogenesis but not ketones themselves. Diabetes 1996;45:1511–5.

    Article  PubMed  CAS  Google Scholar 

  54. Kolaczynski JW, Nyce MR, Considine RV, et al. Acute and chronic effects of insulin on leptin production in humans. Studies in vivo and in vitro. Diabetes 1996;45:699–701.

    Article  PubMed  CAS  Google Scholar 

  55. Kosaki A, Yamada K, Kuzuya H. Reduced expression of the leptin gene (ob) by catecholamine through a Gs-protein-coupled pathway in 3T3-L1 adipocytes. Diabetes 1996;45:1744–9.

    Article  PubMed  CAS  Google Scholar 

  56. Larsson H, Ahren B. Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women. J Clin Endocrinol Metab 1996;81:4428–32.

    Article  PubMed  CAS  Google Scholar 

  57. Larsson H, Elmstahl S, Ahren B. Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women. Diabetes 1996;45:1580–4.

    Article  PubMed  CAS  Google Scholar 

  58. Lee G-H, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996;379:632–5.

    Article  PubMed  CAS  Google Scholar 

  59. Leroy P, Dessolin S, Villageois P, et al. Expression of ob gene in adipose cells. J Biol Chem 1996;271:2365–8.

    Article  PubMed  CAS  Google Scholar 

  60. Lönnquist F, Arner P, Nordfors L, Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nature Med 1995;1:950–3.

    Article  Google Scholar 

  61. Lynn RB, Cao G-Y, Considine RV, Hyde TM, Caro JF. Autoradiographic localization of leptin binding in the choroid plexus of ob/ob and db/db mice. Biochem Biophys Res Commun 1996;219:884–9.

    Article  PubMed  CAS  Google Scholar 

  62. Macdonald IA. Advances in our understanding of the role of the sympathetic nervous system in obesity. Int J Obes 1995;19:2–7.

    Google Scholar 

  63. MacDougald OA, Hwang C-S, Fan H, Lane MD. Regulated expression of the obese gene product (leptin) in white adipose tissue and LT3-L1 adipocytes. Proc Natl Acad Sci 1995;92:9034–7.

    Article  PubMed  CAS  Google Scholar 

  64. Maffei M, Fei H, Lee G-H, et al. Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc Natl Acad Sci 1995;92:6957–60.

    Article  PubMed  CAS  Google Scholar 

  65. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1995;1:1155–61.

    Article  PubMed  CAS  Google Scholar 

  66. Maffei M, Stoffel M, Barone M, et al. Absence of mutations in the human ob gene in obese/diabetic subjects. Diabetes 1996;45:679–82.

    Article  PubMed  CAS  Google Scholar 

  67. Malmström R, Taskinen M-R, Karonen S-L, Yki-Järvinen H. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologica 1996;39:993–6.

    Article  Google Scholar 

  68. Masuzaki H, Ogawa Y, Hosoda K, Kawada T, Fushiki T, Nakao K. Augmented expression of the obese gene in the adipose tissue from rats fed high-fat diet. Biochem Biophys Res Commun 1995;216:355–8.

    Article  PubMed  CAS  Google Scholar 

  69. Masuzaki H, Ogawa Y, Isse N, et al. Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 1995;44: 855–8.

    Article  PubMed  CAS  Google Scholar 

  70. McGregor GP, Desaga JF, Ehlenz K, et al. Radioimmunological measurement of leptin in plasma of obese and diabetic human subjects. Endocrinology 1996;137: 1501–4.

    Article  PubMed  CAS  Google Scholar 

  71. Mercer JG, Hoggard N, Williams LM, Lawrence B, Hannah LT, Trayhurn P. Localization of leptin receptor mRNA and the long form splice variant (ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett 1996;387:113–6.

    Article  PubMed  CAS  Google Scholar 

  72. Mercer JG, Hoggard N, Williams LM, et al. Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 1996;8:733–5.

    Article  PubMed  CAS  Google Scholar 

  73. Mizuno TM, Bergen H, Funahashi T, et al. Obese gene expression: reduction by fasting and stimulation by insulin and glucose in lean mice, and persistent elevation in acquired (diet-induced) and genetic (yellow agouti) obesity. Proc Natl Acad Sci USA 1996;93:3434–8.

    Article  PubMed  CAS  Google Scholar 

  74. Murakami T, Iida M, Shima K. Dexamethasone regulates obese expression in isolated rat adipocytes. Biochem Biophys Res Commun 1995;214:1260–7.

    Article  PubMed  CAS  Google Scholar 

  75. Muscelli E, Camastra S, Masoni A, et al. Acute insulin administration does not affect plasma leptin levels in lean or obese subjects. Eur J Clin Invest 1996;26:940–943.

    Article  PubMed  CAS  Google Scholar 

  76. Niki T, Mori H, Tamori Y, et al. Human obese gene: Molecular screening in Japanese and Asian Indian NIDDM patients associated with obesity. Diabetes 1996;45:675–8.

    Article  PubMed  CAS  Google Scholar 

  77. Ostlund RE, Yang JW, Klein S, Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 1996;81:3909–13.

    Article  PubMed  CAS  Google Scholar 

  78. Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995;269:540–3.

    Article  PubMed  CAS  Google Scholar 

  79. Pratley RE, Nicolson M, Bogardus C, Ravussin E. Effects of acute hyperinsulinemia on plasma leptin concentrations in insulin-sensitive and insulin-resistant Pima Indians. J Clin Endocrinol Metab 1996;861:4418–21.

    Article  Google Scholar 

  80. Reed DR, Ding Y, Xu W, Cather C, Green ED, Price RA. Extreme obesity may be linked to markers flanking the human ob gene. Diabetes 1996;45:691–3.

    Article  PubMed  CAS  Google Scholar 

  81. Rentsch J, Chiesi M. Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett 1996;379:55–9.

    Article  PubMed  CAS  Google Scholar 

  82. Rohner-Jeanrenaud F, Jeanrenaud B. Obesity, leptin, and the brain. N Engl J Med 1996;334:324–5.

    Article  PubMed  CAS  Google Scholar 

  83. Rosenbaum M, Nicolson M, Hirsch J, et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996;81:3424–7.

    Article  PubMed  CAS  Google Scholar 

  84. Saladin R, De Vos P, Guerre-Millo M, et al. Transient increase in obese gene expression after food intake or insulin administration. Nature 1995;377:527–9.

    Article  PubMed  CAS  Google Scholar 

  85. Sarraf P, Frederich RC, Turner EM, et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 1997;185:171–5.

    Article  PubMed  CAS  Google Scholar 

  86. Schwartz MW, Baskin DG, Bukowski TR, et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996;45:531–5.

    Article  PubMed  CAS  Google Scholar 

  87. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nature Med 1996;2:589–93.

    Article  PubMed  CAS  Google Scholar 

  88. Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996;45:988–91.

    Article  PubMed  CAS  Google Scholar 

  89. Sinha MK, Ohannesian JP, Heiman ML, et al. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 1996;97: 1344–7.

    Article  PubMed  CAS  Google Scholar 

  90. Sivitz WI, Bailey HL, Donohoue P. Rat adipose ob mRNA levels in states of altered circulating glucose and insulin. Biochem Biophys Res Commun 1996;220:520–5.

    Article  PubMed  CAS  Google Scholar 

  91. Slieker LJ, Sloop KW, Surface PL, et al. Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem 1996;271:5301–4.

    Article  PubMed  CAS  Google Scholar 

  92. Spitzweg C, Joba W, Mühlberg T, Heufelder AE. Analysis of human leptin receptor mRNA expression in human brain and other tissues (submitted).

  93. Stephens TW, Basinski M, Bristow PK, et al. The role of neuropeptide Y in the anti-obesity action of the obese gene product. Nature 1995;377:530–2.

    Article  PubMed  CAS  Google Scholar 

  94. Takaya K, Ogawa Y, Isse N, et al. Molecular cloning of rat leptin receptor isoform complementary DNAs — Identification of a missense mutation in Zucker Fatty (fa/fa) rats. Biochem Biophys Res Commun 1996;225:75–83.

    Article  PubMed  CAS  Google Scholar 

  95. Tartaglia LA, Dembski M, Wenig X, et al. Identification and expression cloning of a leptin receptor, ob-R. Cell 1995;83:1263–71.

    Article  PubMed  CAS  Google Scholar 

  96. Trayhurn P, Duncan JS, Rayner DV. Acute cold-induced suppression of ob (obese) gene expression in white adipose tissue of mice: mediation by the sympathetic system. Biochem J 1995;311:729–33.

    PubMed  CAS  Google Scholar 

  97. Trayhurn P, Thomas MEA, Duncan JS, Rayner DV. Effects of fasting and refeeding on ob gene expression in white adipose tissue of lean and obese (ob/ob) mice. FEBS Lett 1995;368:488–90.

    Article  PubMed  CAS  Google Scholar 

  98. Utriainen T, Malmström R, Mäkimattila S, Yki-Järvinen H. Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4h in normal subjects. Diabetes 1996;45:1364–6.

    Article  PubMed  CAS  Google Scholar 

  99. Vidal H, Auboeuf D, De Vos P, et al. The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J Clin Invest 1996;98:251–5.

    Article  PubMed  CAS  Google Scholar 

  100. Wabitsch M, Jensen PB, Blum WF, et al. Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 1996;45:1435–8.

    Article  PubMed  CAS  Google Scholar 

  101. Weigle DS, T.R. Bukowski TR, D.C. Foster DC et al. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 1995;96: 2065–70.

    Article  PubMed  CAS  Google Scholar 

  102. Widjaja A, Stratton IM, Horn R, Holman RR, Turner R, Brabant G. UKPDS 20: Plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects. J Clin Endocrinol Metab (in press).

  103. Zarjevski N, Cusin J, Vettor R, Rohner-Jeaurenaud F, Jeaurenaud B. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 1993;133:1753–8.

    Article  PubMed  CAS  Google Scholar 

  104. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425–32.

    Article  PubMed  CAS  Google Scholar 

  105. Zheng D, Jones JP, Usala SJ, Dohm GL. Differential expression of ob mRNA in rat adipose tissues in response to insulin. Biochem Biophys Res Commun 1996;218:434–7.

    Article  PubMed  CAS  Google Scholar 

  106. Zimmet P, Hodge A, Nicolson M, et al. Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. Br Med J 1996;313: 965–9.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Armin E. Heufelder.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spitzweg, C., Joba, W. & Heufelder, A.E. Leptin — Neue Erkenntnisse zur Pathogenese der Adipositas. Med Klin 93, 478–485 (1998). https://doi.org/10.1007/BF03042597

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03042597

Schlüsselwörter

Key Words

Navigation